Simple scan could sharpen deadly lung disease risk predictions
NCT ID NCT07266012
Summary
This study tested whether a new ultrasound scoring method, called VExUS, could help doctors better assess risk in patients with pulmonary arterial hypertension (PAH). Researchers compared the ultrasound score to the standard risk assessment tools and measurements taken during a heart catheterization procedure. The goal was to see if this scan could provide a clearer picture of a patient's condition and help guide their treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istanbul University-Cerrahpasa Institute of Cardiology
Istanbul, FATIH, 34098, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.